摘要
目的探讨腹膜透析在急性重症胰腺炎(SAP)中的治疗效果。方法将40例急性重症胰腺炎患者随机分为两组,即腹膜透析组20例和非透析组20例。透析组于起病后48h内进行透析治疗,非透析组进行常规治疗。观察比较两组血尿淀粉酶的变化,白细胞恢复正常的时间,平均住院时间,治愈率,病死率及并发症发生率。结果在上述各项指标的改善,腹膜透析组明显优于对照组,P<0.05。结论腹膜透析可改善早期急性重症胰腺炎的预后,提高治愈率,降低死亡率和减少并发症发生。
Objective To investigate the therapeatic efficacy of peritoneal dialysis （PD） in the treatment of severe acute pancreatitis （SAP）. Methods 40 cases with SAP were randomily divided into PD group （20 cases） and non-PD group （NPD,20 cases）. PD was applied in PD group within 48 hours after diagnosis, while in NPD group only routine therapy was carried out. change of amylase in blood and urine, WBC count, average hospitalization, mortality, complication and cure rate were collected and analized in the two groups, prospectively. Result In the improvement of every index of mention obove, the PD group was much superior to the NPD group （P〈0.05）.Conclusion PD might improve the prognosis of severe acute pancreatitis. If can increase cure rate and reduce comolication rate and mortality.
出处
《岭南现代临床外科》
2007年第1期19-21,共3页
Lingnan Modern Clinics in Surgery
关键词
腹膜透析
胰腺炎
急性重症
Peritoneal dialysis
severe acute/Pancreatitis
